Outcome Evaluation

• Review the patient's medication profile to ensure that there are no potential/actual pharmacotherapy problems related to dosing, disease-state precautions or contraindications, drug-drug interactions, or unnecessary therapeutic duplication.

• Verify the extent of compliance with pharmacotherapy.

• Assess the response to pharmacotherapy, especially with regard to suicidality and those symptoms that cause significant subjective distress and/or functional impairment.

• Determine whether the patient is experiencing adverse effects of pharmacotherapy. Although general questioning (e.g., "Are you having any side effects?") may reveal some problems with therapy, it is better to use direct questioning concerning adverse effects that are most common and/or most problematic (e.g., "Have you noticed any change in your sexual functioning?").

• Provide counseling to enhance patient understanding of MDD and its pharmaco-therapy.

Abbreviations Introduced in This Chapter

Anxiety and Depression 101

Anxiety and Depression 101

Everything you ever wanted to know about. We have been discussing depression and anxiety and how different information that is out on the market only seems to target one particular cure for these two common conditions that seem to walk hand in hand.

Get My Free Ebook


Post a comment